argenx SE (NAS:ARGX)
$ 585.4 34.59 (6.27%) Market Cap: 35.18 Bil Enterprise Value: 30.03 Bil PE Ratio: 0 PB Ratio: 8.21 GF Score: 80/100

Q2 2019 argenx SE Earnings Call Transcript

Aug 01, 2019 / 01:00PM GMT
Release Date Price: $144.58 (+2.93%)
Operator

Welcome to argenx First Half 2019 Financial Results and Second Quarter Business Update Conference Call. (Operator Instructions) I would now like to introduce Beth DelGiacco, Vice President, Investor Relations at argenx.

Beth DelGiacco
argenx SE - VP of IR - US

Thank you. A press release with our first half 2019 financial results and second quarter business update became available earlier today and can be found on the News and Events section of our website.

Before we start, I'd like to go to Slide 2 to remind you that forward-looking statements may be presented during this call. This may include statements about our future expectations, clinical development, regulatory time lines, the potential success of our product candidates, financial projections and upcoming milestones. Actual results may differ materially from those indicated by these statements. argenx is not under any obligation to update statements regarding the future or to conform those statements in relation to actual results, unless this is required by law.

I'm joined on the call

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot